It is with great bliss to invite you to the official website of the 7^th International Conference on Dementia and Care Practice during August 14-16, 2017 at Toronto, Canada.

The live format of the conference will be accredited with CME and CPD Credits

Dementia Care 2017 is a specially designed cluster conference, organized around the theme "Discernment into Innovative Research & Care Practice approaches towards Dementia", which covers a wide range of critically important sessions from basic research to latest innovations in the field of Dementia and Care Practice.

Dementia, amongst the biggest cosmic public health challenges, is a syndrome – usually of a chronic or progressive nature – in which there is deterioration in cognitive function and mainly affects memory, thinking, orientation, comprehension, calculation, learning capacity, language, and judgement and reasoning problems but not consciousness.

The objective of this session is to comprehend the inducement, Genesis and Diagnosis and prognosis including caregiving of Dementia and further hastening the revivification of dementia.

Track 1: Dementia: Alzheimer’s and Vascular Dementia

Alzheimer's is a kind of dementia that causes dilemma with memory, thinking and behaviour. This mainly happens due to the disruptions caused in nerve cells within the brain. The brains of individuals with Alzheimer disease have an abundance of 2 abnormal structures: amyloid plaques and neurofibrillary tangles that are product of misfolded proteins. This can be very regular in certain regions of the brain that are necessary for memory. Another main feature of Alzheimer’s disease is the loss of connections amidst cells. This results in diminished cell operate and necrobiosis.

Vascular dementia is slump in thinking skills caused by conditions that block or reduce flow of blood to the brain, depriving brain cells of vital oxygen and nutrients. Multiple small strokes or other conditions that affect blood vessels and nerve fibres deep inside the brain cause these accumulations to occur. 

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

3^rd International Conference on Central Nervous System Disorders and Therapeutics September 25-27, 2017 at Vienna, Austria; 3^rd International Conference on Parkinson’s disease & Movement Disorders on June 05-07, 2017 at Milan, Italy; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy: 3^rd International Conference on Spinal Surgery during October 16-18, 2017 at Chicago, USA: 17^th European Neurology Congress on October 15-17, 2017 at Rome, Italy; 11^th World Congress on Neurology and Therapeutics on March 27-29, 2017 at Madrid, Spain; Alzheimer’s Association International Conference July 16 – 20, 2017 at London, England; Alzheimer Foundation of America; Alzheimer's  and Related disorders Society of India; Shiley- Marcos Alzheimer’s Disease Research Centre;  The Alzheimer Society of Ottawa

Track 2: Neurodegenerative Diseases 

Neurodegenerative disease is an allied term for a range of conditions which primarily affect the neurons in the brain and are incurable and attenuate conditions that dynamically result in degeneration or death of nerve cells. Examples of neurodegenerative diseases include Dementia, Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis and Huntington’s disease. The most banal kind of neurodegenerative disorder which people are facing is dementia.

Dementia is a group of conditions characterised by wreckage of at least two brain functions, such as memory loss and judgment. The deficit of brain function is stern enough that an individual cannot do normal activities and leads to such an extent that it interferes with a person’s lifestyle. Additionally, some individuals with dementia cannot manage their emotions. The occurrence of dementia increases emblematically with increasing age. However, it’s not a standard part of aging. Many people live into their 90s beyond with nil signs of dementia.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on Central Nervous System Disorders and Therapeutics on September 25-27, 2017 at Vienna, Austria; 3^rd International Conference on Neuro Infectious Disorders on August  28-30, 2017 at Philadelphia, USA; 3^rd International Conference on Spinal Surgery during October 16-18, 2017 at Chicago, USA: 13th​ International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders on March 29- April 02, 2017 at Vienna, Austria; Alzheimer's Australia National Conference on October 17 – 20, 2017 at Melbourne, Australia; Alzheimer's Australia National;  Alzheimer Society of Canada; Dementia Care Society of Nigeria & Rossetti Care; Dementia Alliance International

Track 3: Dementia Care Research

Amongst the induced and later stages of dementia an individual often involves challenging behavioural problems such as anger, sadness, paranoia, confusion and fear that can further result in oppositional, aggressive and sometimes violent actions.

Although there is currently no cure for dementia and no way to stop the underlying death of brain cells, but dementia research has shown that there is still a leeway to improve the essence of life of people living with dementia by providing a supportive environment to them.  An individual’s centred care is considered important which characterises a clear perceptive of the individual and giving consideration to their cultural background, personal history, social and family networks and preferences for activities in designing their care.

Related   Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

10^th International Conference on Neuroscience and Neurochemistry on February 27 – 28, 2017 at Amsterdam, Netherlands; Conference on Brain Disorders on November 06-08, 2017 at Madrid, Spain; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; World Congress and Expo on Dementia and Neuroscience September 26–28, 2016 at Los Angeles, California: 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy: Clinical Trials on Alzheimer’s Disease (CTAD) on December 8 – 10, 2016 at San Diego, CA, USA; National Cell Repository for Alzheimer’s disease; Mayo Alzheimer’s Disease Research Center; The Alzheimer Society of Ottawa and Renfrew County; American Academy of Neurology ; Center for Cognitive Neurology

Track 4: Dementia Care Practice

Diagnosing dementia and Alzheimer is generally difficult, particularly in the initial stages. However diagnosis assessment incorporates medical and patient history to rule out different possible causes. Therefore numerous diagnostic procedures are needed which further includes neurological and physical examination related to blood and urine tests, Mental status assessment to work out the level of mental deterioration, Brain scans (CT Scans and MRI), Caregiver interview to see the level of dependency,  Mini Mental State Examination (MMSE) can also be recommended.

Aside from these diagnostics, dementia patient needs reassurance and support from the people closest to them - including their carers, friends and family to help the patient to reminisce their sense of existence and feelings of self-worth.

Related  Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

11^th World Congress on Neurology and Therapeutics on March 27-29, 2017 at Madrid, Spain; 14th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA;   International Dementia Conference  June 7-8, 2018, 32^nd International Conference on Alzheimer’s Disease International April 26-29, 2017, Kyoto, Japan; 13^th International Conference on Alzheimer’s & Parkinson’s Diseases on March 29 – April 2, 2017 at Vienna, Australia; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 15^th World Congress on Neurology and Neurological Disorders on August 20-22, 2017 at Paris, France; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 11th World Congress on Controversies in Neurology on March 23-26, 2017 at Athens, Greece; Alzheimer's Association International Conference (AAIC) on July 16-20, 2017 at London, UK; Alzheimer’s Drug Discovery Foundation; Dementia & Alzheimer's caregiver center; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Dementia Alliance International

Track 5: Neurological Nursing

Neurological Nursing is a very provoking nursing specialty which deals with assessment, nursing diagnosis, and management of many neurological disorders for which care practitioners provide patient care regarding neurological disorders such as trauma, brain injuries, dementia, stroke, seizures, tumors, headaches, infections and aneurysms, as well as other neurological intricacies.

Talking about dementia, it encircles many different conditions and is apparent by a loss of cognitive abilities affecting attention, memory, language, logical reasoning and problem-solving skills that interfere with daily activities. It is caused by brain cell deterioration.

Neurological care practitioners commit to give compassionate care to patients suffering from neurological diseases including dementia and Alzheimer, from diagnosis to treatment and beyond.

Related  Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 7^th International Conference on Alzheimer’s Disease and Dementia on October 29-31, 2017 at Brussels, Belgium; 13^th International Conference on Alzheimer’s & Parkinson’s Diseases on March 29 – April 2, 2017 at Vienna, Australia; 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: 2^nd International Conference on Spine and Spinal Disorders during July 24-26, 2017 at Rome, Italy:  10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 3rd Congress of the European Academy of Neurology (EAN) on June 24-27, 2017 at Amsterdam, Netherlands; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Fisher Center for Alzheimer’s Research; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Alzheimer Foundation of America

Track 6: Person living with Dementia

Surviving with dementia from conditions such as Alzheimer’s and related disorders can have an ample of emotional, social, psychological and practical impact on a person. Dementia sufferer finds that their mental abilities are declining, for instance, difficulties to remember things, think clearly, communicate with others, or take care of themselves  and often feel vulnerable and need a great deal of reassurance and support.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

7^th International Conference on Dementia and Care Practice  May 04-05, 2017 Toronto, Canada; 12^th Global Neurologists Annual Meeting on Neurology and Neurosurgery on December 04-06, 2017 at Dubai, UAE; 3^rd Annual Experts Meeting on Depression, Anxiety and Stress Management on November 05-07, 2017 at Madrid, Spain; Annual Dementia Conference  on April 21, 2017;  10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: Human Amyloid Imaging Conference on January 11-13, 2017 at Cambridge, England, UK; Neuroradiology-Brain and Spine 2017 on March 25-26, 2017 at Sydney, Australia; 13th International Conference on Alzheimer`s & Parkinson`s on March 29 – April 02, 2017 at Vienna, Austria; Center for Cognitive Neurology; Canadian Home Care Association; Alzheimer Society of U.K ; Dementia & Alzheimer's caregiver center; Alzheimer's Australia National

Track 7: Age and Dementia

Neurocognitive disorders accounts a class of mental state disorders that essentially affect learning, memory, judgement, and cognitive behaviour, dementia , and delirium. There's no set age for these disorders to happen but it has been found that age-associated memory impairment and dementia increases typically with increasing age.

Geriatrics  scrutinised and stated that people facing dementia whose symptoms started before the age of 65 are often considered as 'younger people with dementia' or as having young-onset dementia and those before the age of 65 are consider  under   “early onset dementia or “working age dementia” category.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

2^nd International Conference on Neurorehabilitation on May 25-26, 2017 at Skokie, IL, United States; 10^th International Conference on Neuroscience and Neurochemistry on February 27-28, 2017 at Amsterdam, Netherlands; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA; 11^th World Congress on Neurology and Therapeutics March 27- 29, 2017 at Madrid, Spain; Fisher Center for Alzheimer’s Research ; Alzheimer Society of Canada ; Dementia Care Society of Nigeria & Rossetti Care ; Dementia Alliance International; Banner Alzheimer’s Initiative; Center for Cognitive Neurology ; Alzheimer Foundation of America

Track 8 : Factors influencing Dementia

Dementia is the case that people over 60 fear the most.  The most common factors which enhances the risk of developing dementia includes ageing, accumulation of  ApoE, Alcohol use, Genetics,  Down syndrome,  Atherosclerosis, Depression,  stroke,  Diabetes,  Hypertension,  Mental illness, smoking,  Unhealthy diet,  Head injuries and many more.

There is no proper cure for dementia; yet medication (including cholinesterase inhibitors containing Donepezil-Rex) and non-drug treatments could give some comfort. However, dementia is not inexorable as we age and there is a lot we can do to dwindle the chances of mellowing it.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

14^th International Conference on Neurology and Neurosurgery on June 21 - 22, 2017 at Paris, France; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 2^nd International Conference on Neuroimaging and Interventional Radiology on June 26-27, 2017 at Philadelphia, USA;  10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 7^th International Conference on Alzheimer’s Disease and Dementia on October 29-31, 2017 at Brussels, Belgium; International Dementia Conference  on June 7- 8, 2018; Alzheimer’s Australia National Conference on October 17 – 20, 2017 at Melbourne, Australia; Alzheimer Disease International; Alzheimer's Research UK; Bright Focus Foundation ; Cure Alzheimer’s Fund;  Alzheimer Society of Ontario

Track 9: Diagnosis and Prognosis of Dementia

Dementia is not a disease; it’s actually a comprehensive term that portrays a wide range of symptoms related with a drop in memory or thinking skills severe enough to turn down a person's aptitude to perform everyday activities.

No single test can disclose if someone is demented or not however, Doctors or physicians can almost rules out if a person has dementia using medical evaluations which comprises of medical history, mental status testing (Mini-mental state examination, Mini-Cog test) , physical and neurological exams, blood tests and brain imaging (CT Scans and MRI).Though treatment for dementia is entering an energising stage, following many new medications depending upon the pathogenesis of Alzheimer’s illness.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

2^nd International Conference on Neurorehabilitation on May 25 – 26, 2017 at Chicago, USA; 13^th International Conference on psychiatric-Mental Health Nursing on September 18-20, 2017 at Chicago, USA; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 11^th World Congress on Neurology and Therapeutics March 27- 29, 2017 at Madrid, Spain;  10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: : 2^nd International Conference on Neuro Oncology and Brain Tumour during April 24-25, 2017 at Dubai, UAE:German Centre for Neurodegenerative Diseases ; National Alzheimer’s Coordinating Center; Fisher Center for Alzheimer’s Research; Banner Alzheimer’s Initiative; Center for Cognitive Neurology; Alzheimer Foundation of America

Track 10: Animal Models and Translational Medicine

Dementia is a syndrome with eccentric memory loss and impaired ability to recall events from the past often characterized by Alzheimer's disease. Animal models for dementia or Alzheimer is important to think about the human phenotype and what is being modelled in terms of the animal phenotype. Animal models of Alzheimer’s disease or dementia, based on the genetics of the disease and the closely related front temporal dementia, replicate at least some of the pathology.

Researchers have been successful at modelling very specific aspects of  Alzheimer in the mouse (e.g., plaques, tangles). Multiple approaches have been adopted to create reliable animal models ranging from rodents to non-human primates, where the animals are exposed to a predetermined injury or causing genetic ablation across specific regions of brain suspected to affect learning functions.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3rd  International Conference on Parkinson’s Disease and Movement Disorders on June 5-7, 2017 at Milan, Italy;14th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; : 2^nd International Conference on Neuro Oncology and Brain Tumour during April 24-25, 2017 at Dubai, UAE: 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: Center for Cognitive Neurology; Canadian Home Care Association; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Bright Focus Foundation; Alzheimer Society of Ontario

Track 11: Biomarkers in Dementia

Experts believe that biomarkers offer most promising paths to diagnose Alzheimer’s or dementia. A biomarker is something that can reliably indicate the presence of disease.

Certain possible biomarkers are being studied for their strength to indicate initial stages of Dementia or Alzheimer's disease such as including beta-amyloid and tau levels in cerebrospinal fluid (CSF) and brain changes detectable by imaging. However, three biomarkers have been well-established and validated internationally to diagnose AD in CSF with ELISAs: β-amyloid (1–42) [Aβ(1–42)], total tau and phospho-tau-181.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

14^th International Conference on Neurology and Neurosurgery on June 21 - 22, 2017 at Paris, France; 14^th Global Neuroscience Conference on July 17-19, 2017 at Chicago, USA; 6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 11^th World Congress on Neurology and Therapeutics during March 27-29, 2017 at Madrid, Spain: 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyNational Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center; Alzheimer Foundation of America; Alzheimer's  and Related disorders Society of India

Track 12: Amyloid Protein in Dementia

 All cells are like minute factories, producing thousands of proteins with precise functions to keep the cells viable. A flaw can occur if a protein is altered, or if excess or too little is formed. Sometimes, the consequences are so severe that a cell dies. Neuron ruination is the chief cause of dementia and is often associated to malfunctions in the connection system that a neuron needs to survive.

Dementia is associated with accumulation of two proteins – amyloid and tau - into plaques and tangles in the brain. Beta-amyloid accumulates as plaques in Alzheimer's disease or dementia and is an endorsement of the disease. Tau compiles into tangles (known as neurofibrillary tangles or NFT). And further disrupts the structure and communication within the nerve cells, leading to cell death.

Related   Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

10^th International Conference on Neuroscience and Neurochemistry on February 27 – 28, 2017 at Amsterdam, Netherlands; Conference on Brain Disorders on November 06-08, 2017 at Madrid, Spain; 6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3^rd International Conference on Central Nervous System Disorders and Therapeutics on September 25-27, 2017 at Vienna, Austria  ; 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyClinical Trials on Alzheimer’s Disease (CTAD) Cure Alzheimer’s Fund ;  Alzheimer Society of Ontario ; Center for Cognitive Neurology ; Canadian Home Care Association; Alzheimer Foundation of America ; Alzheimer's  and Related disorders Society of India

Track 13: Neuropathology

Dementia is among the most typical neurodegenerative diseases which specifically arise due to neuron death. It is now becoming evident that neurodegenerative diseases have a biochemical basis. Many neurodegenerative diseases are inherited. Their genes are known and DNA-based diagnosis (including prenatal diagnosis) is available. Loss of neurons is accompanied by specific histopathological findings such as Alzheimer's plaques and Lewy bodies. Some neurodegenerative diseases engage specific anatomical systems or adjoining sets of neurons. 

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3^rdInternational Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 17^th European Neurology Congress on October 15-17, 2017 at Rome, Italy; 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, Germany:  10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands:Alzheimer Disease International; Alzheimer's Research UK ; Bright Focus Foundation ; Cure Alzheimer’s Fund;  Alzheimer Society of Ontario; John Douglas French Alzheimer's Foundation; National Organization for Rare Disorders (NORD)

Track 14: Neuropharmacology

Dementia is a common clinical phenomenon; however, management of the coexisting illnesses remains incomplete. Neuropsychiatric turmoil is one of the clinical characteristics of Dementia. Traditionally, this turmoil has been managed with neuroleptics or benzodiazepines but accounts serious side effects. With the advancement in the neuropharmacology field, many new-fangled medications came into existence. Donepezil is a piper dine based reversible, non-competitive cholinesterase inhibitor and proved beneficial for the management of symptoms of Alzheimer’s disease covering dementia, a disease in which cholinergic pathways in the cerebral cortex and basal forebrain are well known to be compromised.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

6^th International Conference on Vascular Dementia February 27-March 01, 2017 at Amsterdam, Netherlands; 3rd International Conference on  Central Nervous System Disorders and Therapeutics  on September 25-27, 2017 at Vienna, Austria; Conference on Brain Disorders on November 6-8, 2017 at Madrid, Spain;   10^th International Conference on Neuroscience and Neurochemistry during February 27-28, 2017 at Amsterdam, Netherlands: 2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, GermanyAssociation for Frontotemporal Degeneration (AFTD) ;  Lewy Body Dementia Association; Alzheimer's disease Education and Referral Center (ADEAR); National Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; German Centre for Neurodegenerative Diseases; National Alzheimer’s Coordinating Center

Track 15: Therapeutic Approaches towards Dementia

There are a numerous ways to categorise interventions in dementia care, for instance, by the kind of treatment approach used.  The chief grouping is by the therapeutic goal, with three considerable spheres recommended: the maintenance of function, including cognitive functions, the management of behaviours that challenge and the reduction of comorbid emotional disorders. 

The range of non-pharmacological ‘interventions’ in dementia care is ample and would include the everyday interactions of carers with the person suffering from dementia, the effect of the physical and social conditions and all manner of  ‘therapies’, ranging from art sessions to contact with animals.

Related    Dementia Conference | Care practice Conference | Dementia Care Conference | Neurology Conference

3^rdInternational Conference on Neurological Disorders and Stroke April 24-26, 2017 Dubai, UAE; 6^th International Conference on Vascular Dementia on February 27 – March 01, 2017 at Amsterdam, Netherlands; 3rd  International Conference on Parkinson’s Disease and Movement Disorders on June 5-7, 2017 at Milan, Italy;  2^nd International Conference and Exhibition on Dual Diagnosis during May 15-17, 2017 at Munich, Germany: National Institute of Mental Health (NIMH); National Alzheimer’s Coordinating Center; Banner Alzheimer’s Initiative; Alzheimer Society of U.K; Dementia & Alzheimer's caregiver center; Alzheimer Disease International